Trial record 1 of 1 for:
NCT04637503
4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04637503 |
|
Recruitment Status : Unknown
Verified November 2020 by Shenzhen Geno-Immune Medical Institute.
Recruitment status was: Recruiting
First Posted : November 19, 2020
Last Update Posted : November 19, 2020
|
Sponsor:
Shenzhen Geno-Immune Medical Institute
Collaborator:
Shenzhen Children's Hospital
Information provided by (Responsible Party):
Shenzhen Geno-Immune Medical Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Actual Primary Completion Date : | November 19, 2020 |
| Estimated Study Completion Date : | December 31, 2023 |